Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

QUALI-SMART (01348) Increases Public Shareholding

ISDN Holdings (01656) proposes appointing Lin De Cai as an independent non-executive director.

JensCare-B(09877): JensRoboSiasun Robot & Automation assisted TTVR system completes the first clinical study in humans.
QUALI-SMART (01348) Increases Public Shareholding

ISDN Holdings (01656) proposes appointing Lin De Cai as an independent non-executive director.

JensCare-B(09877): JensRoboSiasun Robot & Automation assisted TTVR system completes the first clinical study in humans.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


